Smart patch could spot dangerous sugar drops after gastric bypass

NCT ID NCT07440706

Recruiting now Disease control Sponsor: Kaiser Clinic and Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a continuous glucose monitor (CGM) can better detect low blood sugar episodes in people who had gastric bypass surgery and now have late dumping syndrome. Sixty participants will either use the iCan i3 CGM or standard fingerstick tests for 60 days. The goal is to see if the CGM catches more hypoglycemic events and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: iCan i3 continuous glucose monitoring system (device)
What this could lead to: If successful, this device could help post-bariatric patients catch dangerous low blood sugar episodes faster and more reliably than fingerstick tests.
What could go wrong: This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The device may not be more effective than standard monitoring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUMPING SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dumping syndrome hypoglycemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DUMPING SYNDROME POST BARIATRIC HYPOGLYCEMIA

Contacts and locations

Locations

Kaiser Clínica Hospital Dia
RECRUITING

São José do Rio Preto, São Paulo, 15015-110, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.